Kernicterus: key aspects of the disease

Authors

  • Ana Clara Abreu Lima de Paula Universidade Federal de Juiz de Fora Author
  • Victória Nunes Oliveira Universidade Federal de Juiz de Fora – Campus Governador Valadares Author
  • Hermes Vinícius Nogueira Neri Centro Universitário de Belo Horizonte Author
  • Gabriel Braga de Castro Centro Universitário de Belo Horizonte Author
  • João Marcos Silva Pontifícia Universidade Católica de Minas Gerais Author
  • Phelipe Von Der Heide Sarmento Universidade de Vassouras Translator
  • Luiza Figueiredo Ribeiro Almeida Faculdade Ciências Médicas de Minas Gerais Author
  • Julia Pitangueira Cardoso Fernandes Faculdade Souza Marques Author
  • Júlia Eduarda Queiroz Grossi Pontifícia Universidade Católica de Minas Gerais – Campus Betim Author
  • Julia Caramatti Ferreira Faculdade Ciências Médicas de Minas Gerais Author

DOI:

https://doi.org/10.5281/zenodo.13182589

Keywords:

Kernicterus, Bilirubin Encephalopathy, Jaundice

Abstract

Kernicterus is a severe neurological condition resulting from the excessive accumulation of unconjugated bilirubin in the central nervous system, typically caused by inadequately treated neonatal hyperbilirubinemia. This condition, associated with toxic levels of bilirubin, can cause irreversible brain damage and lead to serious neurological deficits, such as cerebral palsy, hearing problems, and motor and cognitive disorders. Early detection and appropriate treatment of neonatal jaundice are crucial for preventing kernicterus. Therapeutic approaches include phototherapy and, in more severe cases, exchange transfusion. Additionally, educating parents and healthcare professionals and implementing public policies to ensure universal access to neonatal care are essential to reducing the incidence of the condition. Understanding the pathological mechanisms, along with improving monitoring and treatment practices, is crucial for minimizing the devastating impacts of kernicterus and promoting better outcomes for newborns.

References

AMERICAN ACADEMY OF PEDIATRICS SUBCOMMITTEE ON HYPERBILIRUBINEMIA. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics, 114(1), 297-316, 2004.

BHUTANI, V. K., & JOHNSON, L. Kernicterus in the 21st century: frequently asked questions. Journal of Perinatology, 29 Suppl 1, S20-S24, 2009.

ISKANDER, I., SINGLA, R., & O'NEILL, J. A. Management of jaundice in the newborn: guidelines and controversies. Journal of Pediatrics, 197, 31-35, 2018.

MAISELS, M. J., & MCDONAGH, A. F. Phototherapy for neonatal jaundice. New England Journal of Medicine, 358(9), 920-928, 2008.

PHELPS, D. L., SCHMIDT, R. L., VREMAN, H. J., et al. Phototherapy and bilirubin levels: the effect of light intensity on bilirubin levels. Pediatrics, 124(3), 965-973, 2009.

SHAPIRO, S. M. Definition of the clinical spectrum of kernicterus and bilirubin-induced neurologic dysfunction (BIND). Journal of Perinatology, 25(1), 54-59, 2005.

STEVENSON, D. K., VREMAN, H. J., & WONG, R. J. The role of bilirubin in kernicterus: an update. Pediatrics in Review, 34(11), 477-489, 2013.

WATCHKO, J. F. Kernicterus and the molecular mechanisms of bilirubin-induced CNS injury in newborns. Neuromolecular Medicine, 8(4), 513-529, 2006.

Published

2024-08-03

Issue

Section

Articles

How to Cite

PAULA, Ana Clara Abreu Lima de; OLIVEIRA, Victória Nunes; NERI, Hermes Vinícius Nogueira; CASTRO, Gabriel Braga de; SILVA, João Marcos; ALMEIDA, Luiza Figueiredo Ribeiro; FERNANDES, Julia Pitangueira Cardoso; GROSSI, Júlia Eduarda Queiroz; FERREIRA, Julia Caramatti. Kernicterus: key aspects of the disease. Journal of Social Issues and Health Sciences (JSIHS), [S. l.], v. 1, n. 5, 2024. DOI: 10.5281/zenodo.13182589. Disponível em: https://ojs.thesiseditora.com.br/index.php/jsihs/article/view/65.. Acesso em: 5 dec. 2025.